Copyright Reports & Markets. All rights reserved.

Global Neuroscience Antibodies and Assays Technology Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Neuroscience Antibodies and Assays Technology Market Size 2017-2028
    • 2.1.2 Neuroscience Antibodies and Assays Technology Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Neuroscience Antibodies and Assays Technology Segment by Type
    • 2.2.1 Molecular Diagnostics
    • 2.2.2 Clinical Chemistry
    • 2.2.3 Immunoassay
    • 2.2.4 Immunochemistry
    • 2.2.5 Others
  • 2.3 Neuroscience Antibodies and Assays Technology Market Size by Type
    • 2.3.1 Neuroscience Antibodies and Assays Technology Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Neuroscience Antibodies and Assays Technology Market Size Market Share by Type (2017-2022)
  • 2.4 Neuroscience Antibodies and Assays Technology Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Diagnostics Center
    • 2.4.3 Pharmaceutical and Biotechnology Company
    • 2.4.4 Others
  • 2.5 Neuroscience Antibodies and Assays Technology Market Size by Application
    • 2.5.1 Neuroscience Antibodies and Assays Technology Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Neuroscience Antibodies and Assays Technology Market Size Market Share by Application (2017-2022)

3 Neuroscience Antibodies and Assays Technology Market Size by Player

  • 3.1 Neuroscience Antibodies and Assays Technology Market Size Market Share by Players
    • 3.1.1 Global Neuroscience Antibodies and Assays Technology Revenue by Players (2020-2022)
    • 3.1.2 Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Players (2020-2022)
  • 3.2 Global Neuroscience Antibodies and Assays Technology Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Neuroscience Antibodies and Assays Technology by Regions

  • 4.1 Neuroscience Antibodies and Assays Technology Market Size by Regions (2017-2022)
  • 4.2 Americas Neuroscience Antibodies and Assays Technology Market Size Growth (2017-2022)
  • 4.3 APAC Neuroscience Antibodies and Assays Technology Market Size Growth (2017-2022)
  • 4.4 Europe Neuroscience Antibodies and Assays Technology Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Neuroscience Antibodies and Assays Technology Market Size by Country (2017-2022)
  • 5.2 Americas Neuroscience Antibodies and Assays Technology Market Size by Type (2017-2022)
  • 5.3 Americas Neuroscience Antibodies and Assays Technology Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Neuroscience Antibodies and Assays Technology Market Size by Region (2017-2022)
  • 6.2 APAC Neuroscience Antibodies and Assays Technology Market Size by Type (2017-2022)
  • 6.3 APAC Neuroscience Antibodies and Assays Technology Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Neuroscience Antibodies and Assays Technology by Country (2017-2022)
  • 7.2 Europe Neuroscience Antibodies and Assays Technology Market Size by Type (2017-2022)
  • 7.3 Europe Neuroscience Antibodies and Assays Technology Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Neuroscience Antibodies and Assays Technology by Region (2017-2022)
  • 8.2 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Neuroscience Antibodies and Assays Technology Market Forecast

  • 10.1 Global Neuroscience Antibodies and Assays Technology Forecast by Regions (2023-2028)
    • 10.1.1 Global Neuroscience Antibodies and Assays Technology Forecast by Regions (2023-2028)
    • 10.1.2 Americas Neuroscience Antibodies and Assays Technology Forecast
    • 10.1.3 APAC Neuroscience Antibodies and Assays Technology Forecast
    • 10.1.4 Europe Neuroscience Antibodies and Assays Technology Forecast
    • 10.1.5 Middle East & Africa Neuroscience Antibodies and Assays Technology Forecast
  • 10.2 Americas Neuroscience Antibodies and Assays Technology Forecast by Country (2023-2028)
    • 10.2.1 United States Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.2.2 Canada Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.2.3 Mexico Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.2.4 Brazil Neuroscience Antibodies and Assays Technology Market Forecast
  • 10.3 APAC Neuroscience Antibodies and Assays Technology Forecast by Region (2023-2028)
    • 10.3.1 China Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.3.2 Japan Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.3.3 Korea Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.3.4 Southeast Asia Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.3.5 India Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.3.6 Australia Neuroscience Antibodies and Assays Technology Market Forecast
  • 10.4 Europe Neuroscience Antibodies and Assays Technology Forecast by Country (2023-2028)
    • 10.4.1 Germany Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.4.2 France Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.4.3 UK Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.4.4 Italy Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.4.5 Russia Neuroscience Antibodies and Assays Technology Market Forecast
  • 10.5 Middle East & Africa Neuroscience Antibodies and Assays Technology Forecast by Region (2023-2028)
    • 10.5.1 Egypt Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.5.2 South Africa Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.5.3 Israel Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.5.4 Turkey Neuroscience Antibodies and Assays Technology Market Forecast
    • 10.5.5 GCC Countries Neuroscience Antibodies and Assays Technology Market Forecast
  • 10.6 Global Neuroscience Antibodies and Assays Technology Forecast by Type (2023-2028)
  • 10.7 Global Neuroscience Antibodies and Assays Technology Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Abcam
    • 11.1.1 Abcam Company Information
    • 11.1.2 Abcam Neuroscience Antibodies and Assays Technology Product Offered
    • 11.1.3 Abcam Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Abcam Main Business Overview
    • 11.1.5 Abcam Latest Developments
  • 11.2 BioLegend
    • 11.2.1 BioLegend Company Information
    • 11.2.2 BioLegend Neuroscience Antibodies and Assays Technology Product Offered
    • 11.2.3 BioLegend Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 BioLegend Main Business Overview
    • 11.2.5 BioLegend Latest Developments
  • 11.3 Siemens
    • 11.3.1 Siemens Company Information
    • 11.3.2 Siemens Neuroscience Antibodies and Assays Technology Product Offered
    • 11.3.3 Siemens Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Siemens Main Business Overview
    • 11.3.5 Siemens Latest Developments
  • 11.4 Bio-Rad
    • 11.4.1 Bio-Rad
    • 11.4.2 Bio-Rad
    • 11.4.3 Bio-Rad
    • 11.4.4 Bio-Rad
    • 11.4.5 Bio-Rad
  • 11.5 Genscript Biotech
    • 11.5.1 Genscript Biotech Company Information
    • 11.5.2 Genscript Biotech Neuroscience Antibodies and Assays Technology Product Offered
    • 11.5.3 Genscript Biotech Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Genscript Biotech Main Business Overview
    • 11.5.5 Genscript Biotech Latest Developments
  • 11.6 Rockland Immunochemicals
    • 11.6.1 Rockland Immunochemicals Company Information
    • 11.6.2 Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Product Offered
    • 11.6.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Rockland Immunochemicals Main Business Overview
    • 11.6.5 Rockland Immunochemicals Latest Developments
  • 11.7 Cell Signaling Technology
    • 11.7.1 Cell Signaling Technology Company Information
    • 11.7.2 Cell Signaling Technology Neuroscience Antibodies and Assays Technology Product Offered
    • 11.7.3 Cell Signaling Technology Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Cell Signaling Technology Main Business Overview
    • 11.7.5 Cell Signaling Technology Latest Developments
  • 11.8 Merck
    • 11.8.1 Merck Company Information
    • 11.8.2 Merck Neuroscience Antibodies and Assays Technology Product Offered
    • 11.8.3 Merck Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Merck Main Business Overview
    • 11.8.5 Merck Latest Developments
  • 11.9 Tecan Group
    • 11.9.1 Tecan Group Company Information
    • 11.9.2 Tecan Group Neuroscience Antibodies and Assays Technology Product Offered
    • 11.9.3 Tecan Group Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Tecan Group Main Business Overview
    • 11.9.5 Tecan Group Latest Developments
  • 11.10 Santa Cruz Biotechnology
    • 11.10.1 Santa Cruz Biotechnology Company Information
    • 11.10.2 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Product Offered
    • 11.10.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Santa Cruz Biotechnology Main Business Overview
    • 11.10.5 Santa Cruz Biotechnology Latest Developments
  • 11.11 Thermo Fisher Scientific
    • 11.11.1 Thermo Fisher Scientific Company Information
    • 11.11.2 Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Product Offered
    • 11.11.3 Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Thermo Fisher Scientific Main Business Overview
    • 11.11.5 Thermo Fisher Scientific Latest Developments
  • 11.12 Enzo Life Sciences
    • 11.12.1 Enzo Life Sciences Company Information
    • 11.12.2 Enzo Life Sciences Neuroscience Antibodies and Assays Technology Product Offered
    • 11.12.3 Enzo Life Sciences Neuroscience Antibodies and Assays Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Enzo Life Sciences Main Business Overview
    • 11.12.5 Enzo Life Sciences Latest Developments

12 Research Findings and Conclusion

The global market for Neuroscience Antibodies and Assays Technology is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Neuroscience Antibodies and Assays Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Neuroscience Antibodies and Assays Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Neuroscience Antibodies and Assays Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Neuroscience Antibodies and Assays Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Neuroscience Antibodies and Assays Technology players cover Abcam, BioLegend, Siemens, Bio-Rad
and Genscript Biotech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Neuroscience Antibodies and Assays Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Neuroscience Antibodies and Assays Technology market, with both quantitative and qualitative data, to help readers understand how the Neuroscience Antibodies and Assays Technology market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Neuroscience Antibodies and Assays Technology market and forecasts the market size by Type (Molecular Diagnostics, Clinical Chemistry and Immunoassay), by Application (Hospitals, Diagnostics Center, Pharmaceutical and Biotechnology Company and Others), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Molecular Diagnostics
Clinical Chemistry
Immunoassay
Immunochemistry
Others

Segmentation by application
Hospitals
Diagnostics Center
Pharmaceutical and Biotechnology Company
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Abcam
BioLegend
Siemens
Bio-Rad

Genscript Biotech
Rockland Immunochemicals
Cell Signaling Technology
Merck
Tecan Group
Santa Cruz Biotechnology
Thermo Fisher Scientific
Enzo Life Sciences

Chapter Introduction
Chapter 1: Scope of Neuroscience Antibodies and Assays Technology, Research Methodology, etc.
Chapter 2: Executive Summary, global Neuroscience Antibodies and Assays Technology market size and CAGR, Neuroscience Antibodies and Assays Technology market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Neuroscience Antibodies and Assays Technology revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Neuroscience Antibodies and Assays Technology revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Neuroscience Antibodies and Assays Technology market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abcam, BioLegend, Siemens, Bio-Rad
, Genscript Biotech, Rockland Immunochemicals, Cell Signaling Technology, Merck and Tecan Group, etc.
Chapter 14: Research Findings and Conclusion
Buy now